Advances in Bioengineering and Biomedical Science Research(ABBSR)
ISSN: 2640-4133 | DOI: 10.33140/ABBSR
Impact Factor: 1.7
Caprini Thrombosis Risk Assessment Scale in Evaluating the Effect of Thrombosis Risk in Patients with Malignant Tumors and the Value of Clinical Treatment Guidances
Abstract
XiaoHua Tang, Yin Zhang
Objective: To explore the effect of Caprini Thrombosis Risk Assessment Scale in evaluating the risk of thrombosis in patients with malignant tumors and the value of clinical treatment guidances.
Methods: 78 patients with malignant tumor thrombosis from April 2018 to February 2020 were selected as the observation group; 67 non-thrombotic patients with malignant tumors treated in the same period were selected as the control group. After the two groups were admitted to the hospital, the relevant examinations were improved, and the Caprini Thrombosis Risk Assessment Scale was used to assess the risk of thrombosis in the patients, and the possible influencing factors were analyzed by single factor and correlation analysis; ROC curve was drawn to analyze the Caprini Thrombosis Risk Assessment Scale The efficacy of treatment guidances in the risk of thrombosis in patients with malignant tumors.
Results: The univariate results showed that the incidence of thrombosis in patients with malignant tumors was not statistically significant with gender, age, white blood cell count, platelet count, combined chronic diseases and mortality during hospitalization (P>0.05); it was statistically significant with hematocrit and length of hospitalization (P<0.05); 15 cases of low-medium risk, 21 high-risk, 42 extremely high-risk, the results showed: the higher the Caprini Thrombosis Risk Assessment Scale score, the higher the incidence of DVT (P<0.05); ROC curve results It shows that the Caprini Thrombosis Risk Assessment Scale has an AUC value of 0.867, a treatment guidance sensitivity of 0.871%, and a specificity of 0.636% in the thrombosis risk of patients with malignant tumors.
Conclusion: The Caprini Thrombosis Risk Assessment Scale has a certain predictive value in the thrombosis risk of patients with malignant tumors. It can obtain high sensitivity for treatment guidance and is worthy of popularization and application.